Teva Pharmaceutical Seeks to Intervene in Plan B Lawsuit

Teva Pharmaceutical Industries Ltd. sought to intervene in a lawsuit between the Center for Reproductive Rights and the U.S. government over emergency contraceptives, saying loosening sales restrictions on generics could threaten its marketing rights for Plan B One-Step.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.